Dual JAK/ROCK Inhibition in Rheumatoid Arthritis: Results of a Phase II Study Of CPL’116
Pankoewicz, Kaza, Banach, and Kogut are or were employees during the trial of Celon Pharma
Authors
- Piotr Pankiewicz (ORCID: https://orcid.org/0000-0001-5566-8567)
- Michał Kaza (ORCID: https://orcid.org/0000-0001-6691-7725)
- Bartłomiej Kisiel (ORCID: https://orcid.org/0000-0001-6311-0475)
- Izabella Kierzkowska
- Iryna V Kurylchyk
- Dorota Włodarczyk (ORCID: https://orcid.org/0000-0002-0707-9503)
- Ivan Vyshnyvetskyy (ORCID: https://orcid.org/0000-0001-7228-3052)
- Martyna Banach
- Maciej Wieczorek
- Piotr Leszczyński (ORCID: https://orcid.org/0000-0003-2174-8811)
- John B. Kogut
Institutions
- Poznan University of Medical Sciences (PL)
- National Academy of Medicine (US)
- Centrum Kopernika Badań Interdyscyplinarnych (PL)
- Celon Pharma (Poland) (PL)
- Narodowy Instytut Leków (PL)
- Bogomolets National Medical University (UA)
Publication Details
- Journal
- EMJ Rheumatology
- Published
- 2025-07-24
- DOI
- https://doi.org/10.33590/emjrheumatol/nrjs3946
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission